Aspirin for Primary and Secondary Prevention of Cardiovascular Disease

Tex Heart Inst J. 2016 Aug 1;43(4):318-9. doi: 10.14503/THIJ-16-5807. eCollection 2016 Aug.
No abstract available

Keywords: Anti-inflammatory agents, non-steroidal; aspirin/history/therapeutic use; history, 19th century; history, 20th century; myocardial infarction/prevention & control; platelet aggregation inhibitors; prevention, primary; prevention, secondary; stroke/prevention & control; vascular disease.

MeSH terms

  • Aged
  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Cardiovascular Agents / adverse effects
  • Cardiovascular Agents / therapeutic use*
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / prevention & control*
  • Female
  • Hemorrhage / chemically induced
  • Humans
  • Male
  • Middle Aged
  • Primary Prevention / methods*
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Secondary Prevention / methods*
  • Treatment Outcome

Substances

  • Cardiovascular Agents
  • Aspirin